指南与共识产科母胎医学

低剂量阿司匹林预防子痫前期:是时候重新考虑我们的推荐了吗?

Low-dose aspirin therapy for the prevention of preeclampsia: time to reconsider our recommendations?
指南 / 共识 · Am J Obstet Gynecol · 2023-04-27

本文综述各主要机构对低剂量阿司匹林预防子痫前期的推荐,指出每日>100 mg且在16周前启动似乎最有效,而多数主要学会推荐的剂量可能无效,需开展81 mg与162 mg每日比较的随机对照试验。

要点

  • 美国妇产科医师学会推荐高危孕妇每日81 mg阿司匹林,于12至28周启动,最好在16周前,持续至分娩。
  • 世界卫生组织推荐高危孕妇在20周前启动每日75 mg阿司匹林。
  • 综述现有证据提示每日>100 mg且在16周前启动似乎最有效,多数主要学会推荐的剂量可能无效。

核心结论

  • 综述现有证据提示阿司匹林的剂量和启动时机均是其降低子痫前期风险效果的关键,每日>100 mg且在16周前启动似乎最有效,因此多数主要学会和组织推荐的剂量可能无效。
  • 需要开展比较每日81 mg与162 mg阿司匹林预防子痫前期的随机对照试验,以评估美国可用阿司匹林剂量的安全性和有效性。

研究设计与样本

  • 本文为综述,汇总各主要学会和组织关于低剂量阿司匹林预防子痫前期的推荐及现有证据。

主要发现

  • 美国妇产科医师学会推荐有子痫前期风险的女性每日启动81 mg阿司匹林,于12至28周之间,最好在16周前,持续至分娩。
  • 世界卫生组织推荐子痫前期高危女性在20周前启动75 mg阿司匹林。
  • 皇家学院(Royal College of Obstetricians and Gynaecologists)和英国国家卫生与临床优化研究所(National Institute of Health and Care Excellence)关于「子痫前期风险产前评估」的质量声明要求医疗保健提供者为子痫前期风险增加的孕妇从12周起每日处方低剂量阿司匹林。
  • 皇家学院推荐每日150 mg阿司匹林,英国国家卫生与临床优化研究所指南建议风险分层,对子痫前期中危者给予75 mg,对高危者给予150 mg。
  • 国际妇产科联盟(International Federation of Gynecology and Obstetrics)子痫前期倡议推荐在11至14+6周启动150 mg阿司匹林,并提出2片81 mg是可接受的替代方案。

关键数值与推荐

  • 美国妇产科医师学会:每日81 mg,12至28周启动,最好16周前,持续至分娩。
  • 世界卫生组织:每日75 mg,20周前启动,用于子痫前期高危女性。
  • 皇家学院:每日150 mg,从12周起。
  • 英国国家卫生与临床优化研究所:中危者每日75 mg,高危者每日150 mg,从12周起。
  • 国际妇产科联盟:150 mg于11至14+6周启动,2片81 mg为可接受的替代方案。

临床怎么用

  • 作者认为每日>100 mg且在16周前启动似乎最有效,多数主要学会和组织推荐的剂量可能无效。
  • 作者提出需要开展每日81 mg与162 mg阿司匹林比较的随机对照试验,以评估美国可用剂量的安全性和有效性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The American College of Obstetricians and Gynecologists recommends initiation of 81 mg of aspirin daily for women at risk of preeclampsia between 12 and 28 weeks' gestation, optimally before 16 weeks, with continuation until delivery. The World Health Organization recommends that 75 mg of aspirin should be initiated before 20 weeks of gestation for women at high risk of preeclampsia. Both the Royal College of Obstetricians and Gynaecologists and the National Institute of Health and Care Excellence quality statement on "Antenatal Assessment of Pre-eclampsia Risk" request that healthcare providers prescribe low-dose aspirin to pregnant women at increased risk of preeclampsia daily from 12 weeks of gestation. The Royal College of Obstetricians and Gynaecologists recommends 150 mg of aspirin daily, and the National Institute of Health and Care Excellence guidelines suggest risk stratification with a dosage of 75 mg for those at moderate risk of preeclampsia and 150 mg for those at high risk of preeclampsia. The International Federation of Gynecology and Obstetrics initiative on preeclampsia recommends 150 mg of aspirin to be initiated at 11 to 14+6 week's gestation and also proposes that 2 tablets of 81 mg is an acceptable alternative. Review of the available evidence suggests that both the dosage and timing of aspirin initiation is key to its effectiveness at reducing the risk of preeclampsia. Doses of >100 mg of aspirin daily initiated before 16 weeks' gestation seem to be most effective at reducing the risk of preeclampsia and thus dosages recommended by most major societies and organizations may not be effective. Randomized control trials examining 81 mg vs 162 mg of aspirin daily for the prevention of preeclampsia are required to assess the safety and efficacy of aspirin dosages available in the United States.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Horgan R, Hage Diab Y, Waller J, et al. Low-dose aspirin therapy for the prevention of preeclampsia: time to reconsider our recommendations? Am J Obstet Gynecol. 2023. PMID: 37120049. doi:10.1016/j.ajog.2023.04.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。